Adcetris

Medicinal product

(Invented) name

Adcetris

Active substance (s)

Brentuksimabas vedotinas

Strength

50 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX05, brentuximab vedotin

Marketing authorisation holder

Takeda Pharma A/S, Danija

Date of authorisation

2012-10-25

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Brentuksimabas vedotinas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
54363	68355	1068355	flakonas	N1		Receptinis	EU/1/12/794/001	Netiekiama	2024-10-22	2025-12-31	Yes	2024-10-24	2025-12-31

Stadijos

Data	Stadija
2012-10-25	Registruotas